Navin Fluorine International will hold analyst/investor meetings on September 15 and 16, 2025. Q1FY26 results show robust growth: Sales at Rs 725.4 Cr (+39% YoY) and Operating EBITDA at Rs 206.8 Cr (+106% YoY), with margins expanding to 28.5%. The company sees strong order books across Specialty Chemicals and CDMO. Key projects include AHF capex expected by Q2FY26 and cGMP4 Phase 1 by Q3FY26, driving future growth. Strategic partnerships, R&D focus, and ESG initiatives highlight commitment to sustainable expansion.